股本结构
单位：万股
| 公告日期 | 2024-05-14 | 2024-04-08 | 2024-03-05 | 2024-03-05 | 2023-11-09 | 2023-11-09 |
|---|---|---|---|---|---|---|
| 证券总股本 | 267.90 | 260.00 | 4550.45 | 4427.00 | 3114.43 | 3113.03 |
| 普通股本 | 267.90 | 260.00 | 4550.45 | 4427.00 | 3114.43 | 3113.03 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-30 | 2024-04-10 | 2024-03-01 | 2023-12-31 | 2023-11-03 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-05-14 | 267.90 | 未披露 | 定期报告 | 2024-04-30 |
| 2024-04-08 | 260.00 | 未披露 |
更多>>
a reverse stock split of the Company’s common stock at a ratio of one-for-twenty
|
2024-04-10 |
| 2024-03-05 | 4550.45 | 未披露 | 定期报告 | 2024-03-01 |
| 2024-03-05 | 4427.00 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common stock under equity plans
Issuance of common stock and warrants, net of offering costs
Issuance of common stock upon cashless exercise of pre-funded warrants
|
2023-12-31 |
| 2023-11-09 | 3114.43 | 未披露 | 定期报告 | 2023-11-03 |
| 2023-11-09 | 3113.03 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock, net of offering costs
|
2023-09-30 |
| 2023-08-14 | 3069.99 | 未披露 | 定期报告 | 2023-08-11 |
| 2023-08-07 | 2832.72 | 未披露 | 定期报告 | 2023-08-02 |
| 2023-08-14 | 2662.96 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock, net of offering costs
Issuance of common stock under equity plans
|
2023-06-30 |
| 2023-05-19 | 2474.60 | 未披露 | 定期报告 | 2023-05-16 |
| 2023-05-10 | 2405.95 | 未披露 | 定期报告 | 2023-05-04 |
| 2023-05-10 | 2402.79 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-03-08 | 2382.25 | 未披露 | 定期报告 | 2023-02-21 |
| 2023-03-08 | 2312.53 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock and warrants, net of offering costs
Issuance of common stock under equity plans
Issuance of common stock upon cashless exercise of pre-funded warrants
|
2022-12-31 |
| 2022-11-14 | 2221.14 | 未披露 | 定期报告 | 2022-11-11 |
| 2022-11-14 | 2174.99 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock, net of offering costs
|
2022-09-30 |
| 2022-08-10 | 2142.18 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock under equity plans
Issuance of common stock and warrants, net of offering costs
|
2022-06-30 |
| 2022-07-15 | 2109.42 | 未披露 | 定期报告 | 2022-06-29 |
| 2022-06-23 | 2046.89 | 未披露 |
更多>>
1.Common stock offered by 841,989 shares.
2.The number of shares of common stock to be outstanding immediately after the offering is based on 19,626,960 shares of common stock outstanding as of March 31, 2022
|
2022-06-23 |
| 2022-06-21 | 2025.22 | 未披露 | 定期报告 | 2022-06-17 |
| 2022-05-11 | 2007.95 | 未披露 | 定期报告 | 2022-04-29 |
| 2022-04-25 | 1986.78 | 未披露 | 定期报告 | 2022-04-20 |
| 2022-05-11 | 1962.70 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuances of common stock, net of offering costs
Issuances of common stock upon cashless exercise of pre-funded warrants
|
2022-03-31 |
| 2022-03-16 | 1961.66 | 未披露 | 定期报告 | 2022-03-11 |
| 2022-04-25 | 1961.66 | 未披露 | 定期报告 | 2022-02-28 |
| 2022-03-15 | 1944.59 | 未披露 |
更多>>
from December 31, 2020 to December 31, 2021
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
|
2021-12-31 |
| 2021-11-03 | 1943.04 | 未披露 |
更多>>
from June 30, 2021 to September 30, 2021
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
|
2021-09-30 |
| 2021-08-11 | 1943.04 | 未披露 | 定期报告 | 2021-07-30 |
| 2021-07-26 | 1940.75 | 未披露 |
更多>>
1.Common stock offered 3,926,702 shares.
2.The number of shares of common stock to be outstanding immediately after the offering is based on 15,480,811 shares of common stock outstanding as of March 31, 2021.
|
2021-07-26 |
| 2021-08-11 | 1550.20 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock under equity plans
|
2021-06-30 |
| 2021-05-05 | 1550.20 | 未披露 | 定期报告 | 2021-04-30 |
| 2021-05-05 | 1548.08 | 未披露 |
更多>>
from December 31, 2020 to March 31, 2021
Issuance of common stock under equity plans
|
2021-03-31 |
| 2021-02-25 | 1547.88 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock under equity plans
Issuances of common stock and warrants, net of offering costs
Issuance of common stock in exchange for services
|
2020-12-31 |
| 2020-12-30 | 1529.55 | 未披露 |
更多>>
1.Common stock offered by the company 520,291 shares.
2.The number of shares of common stock to be outstanding immediately after the offering is based on 14,775,206 shares of common stock outstanding as of September 30, 2020, after giving effect to sale of 1,092,553 shares of common stock in a prior registered direct offering in December 2020.
|
2020-12-30 |
| 2020-12-22 | 1477.52 | 未披露 |
更多>>
1.Common stock offered by the company 1,092,553 shares.
2.The number of shares of common stock to be outstanding immediately after the offering is based on 13,682,653 shares of common stock outstanding as of September 30, 2020.
|
2020-12-22 |
| 2020-10-30 | 1368.48 | 未披露 | 定期报告 | 2020-10-26 |
| 2020-11-10 | 1368.27 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuances of common stock and warrants, net of offering costs
|
2020-09-30 |
| 2020-09-04 | 1318.27 | 未披露 | 定期报告 | 2020-08-31 |
| 2020-08-05 | 849.87 | 未披露 | 定期报告 | 2020-07-31 |
| 2020-08-05 | 777.38 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
|
2020-06-30 |
| 2020-05-13 | 550.04 | 未披露 | 定期报告 | 2020-05-08 |
| 2020-05-13 | 549.79 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
Issuance of common stock in exchange for services
|
2020-03-31 |
| 2020-02-28 | 539.79 | 未披露 | 定期报告 | 2020-02-14 |
| 2020-02-28 | 405.12 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
|
2019-12-31 |
| 2019-11-06 | 313.91 | 未披露 |
更多>>
On November 6, 2019, TRACON Pharmaceuticals, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”) at which the Company’s stockholders approved a proposal to amend the Company’s Amended and Restated Certificate of Incorporation to (i) effect a reverse stock split of the Company’s outstanding common stock at a ratio in the range of one-for-five to one-for-twenty, with such ratio to be determined in the discretion of the Company’s board of directors and with such reverse stock split to be effected at such time and date, if at all, as determined by the Company’s board of directors in its sole discretion, and (ii) reduce the number of authorized shares of the Company’s common stock in a corresponding proportion to the reverse stock split, rounded to the nearest whole share (collectively, the “Reverse Split Proposal”).
|
2019-11-08 |
| 2019-10-22 | 3139.06 | 未披露 | 定期报告 | 2019-10-21 |
| 2019-11-12 | 299.37 | 未披露 | 定期报告 | 2019-10-18 |
| 2019-08-07 | 2993.75 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Issuance of common stock under equity plans
|
2019-06-30 |
| 2019-05-14 | 2993.75 | 未披露 | 定期报告 | 2019-05-10 |
| 2019-05-14 | 2989.87 | 未披露 |
更多>>
From December 31, 2018 To March 31, 2019
Issuance of common stock under equity plans
|
2019-03-31 |
| 2019-03-01 | 2989.87 | 未披露 | 定期报告 | 2019-02-06 |
| 2019-03-01 | 2987.13 | 未披露 |
更多>>
From December 31, 2017 To December 31, 2018
Issuance of common stock under equity plans
Issuances of common stock and warrants, net of offering costs
|
2018-12-31 |
| 2018-11-07 | 2987.13 | 未披露 | 定期报告 | 2018-11-02 |
| 2018-11-07 | 2984.08 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-08-08 | 2984.08 | 未披露 | 定期报告 | 2018-08-03 |
| 2018-08-08 | 2982.96 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-04-25 | 2973.13 | 未披露 | 定期报告 | 2018-04-20 |
| 2018-04-25 | 2968.05 | 未披露 | 定期报告 | 2018-04-06 |
| 2018-05-10 | 2844.15 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-01 | 1774.99 | 未披露 | 定期报告 | 2018-02-09 |
| 2018-03-01 | 1771.19 | 未披露 |
更多>>
From December 31, 2016 To December 31, 2017
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
|
2017-12-31 |
| 2017-11-07 | 1751.19 | 未披露 | 定期报告 | 2017-11-03 |
| 2017-11-07 | 1739.31 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-08 | 1665.59 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-10 | 1660.91 | 未披露 | 定期报告 | 2017-05-04 |
| 2017-05-10 | 1658.36 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-27 | 1658.36 | 未披露 | 定期报告 | 2017-03-15 |
| 2017-03-27 | 1616.57 | 未披露 | 定期报告 | 2017-03-14 |
| 2017-03-01 | 1616.36 | 未披露 | 定期报告 | 2017-02-12 |
| 2017-03-01 | 1608.47 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Issuance of common stock under equity plans
Issuance of common stock in a public offering, net of offering costs
Other issuances of common stock, net
Issuance of common stock in exchange for services
|
2016-12-31 |
| 2016-11-09 | 1306.60 | 未披露 | 定期报告 | 2016-11-04 |
| 2016-11-09 | 1305.63 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-11 | 1220.39 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-11 | 1220.39 | 未披露 | 定期报告 | 2016-05-05 |
| 2016-02-01 | 1218.52 | 未披露 | 定期报告 | 2016-01-25 |
| 2016-02-19 | 1217.59 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Conversion of redeemable convertible preferred stock into common stock at initial public offering
Initial public offering and private placement of common stock for cash of $10 per share, net of offering costs
Issuance of common stock under equity plans
On January 16, 2015, the Company effected a one-for-3.87 reverse stock split of its common stock (the Reverse Stock Split).
|
2015-12-31 |
| 2015-11-04 | 1217.59 | 未披露 | 定期报告 | 2015-10-30 |
| 2015-11-04 | 1216.09 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-05-14 | 1210.34 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-11 | 1210.34 | 未披露 | 定期报告 | 2015-03-02 |
| 2015-02-02 | 1209.28 | 未披露 |
更多>>
the conversion of all our outstanding redeemable convertible preferred stock as of September 30, 2014 into an aggregate of 6,369,567 shares of common stock, which will occur automatically in connection with the closing of this offering; a 1-for-3.87 reverse stock split of our common stock effected in January 2015.
|
2015-01-30 |
| 2015-01-20 | 162.32 | 2465.03 |
更多>>
On January 16, 2015, the Company effected a one-for-3.87 reverse stock split of its common stock (the Reverse Stock Split).
|
2015-01-20 |
| 2015-03-11 | 163.39 | 2465.03 |
更多>>
from December 31, 2013 to December 31, 2014
Issuance of Series B redeemable convertible preferred stock in September for cash of $2.1935 per share, net of offering costs of $1,546
Exercise of common stock options
|
2014-12-31 |
| 2014-12-29 | 628.23 | 2465.03 |
更多>>
from December 31, 2013 to September 30, 2014
Issuance of Series B redeemable convertible preferred stock in September for cash of $2.1935 per share, net of offering costs of $1,530 (unaudited)
Exercise of common stock options (unaudited)
|
2014-09-30 |
a reverse stock split of the Company’s common stock at a ratio of one-for-twenty
From December 31,2022 to December 31,2023
Issuance of common stock under equity plans
Issuance of common stock and warrants, net of offering costs
Issuance of common stock upon cashless exercise of pre-funded warrants
From June 30, 2023 to September 30, 2023
Issuance of common stock, net of offering costs
From March 31, 2023 to June 30, 2023
Issuance of common stock, net of offering costs
Issuance of common stock under equity plans
From December 31, 2021 to December 31, 2022
Issuance of common stock and warrants, net of offering costs
Issuance of common stock under equity plans
Issuance of common stock upon cashless exercise of pre-funded warrants
From June 30, 2022 to September 30, 2022
Issuance of common stock, net of offering costs
From March 31, 2022 to June 30, 2022
Issuance of common stock under equity plans
Issuance of common stock and warrants, net of offering costs
1.Common stock offered by 841,989 shares.
2.The number of shares of common stock to be outstanding immediately after the offering is based on 19,626,960 shares of common stock outstanding as of March 31, 2022
From December 31, 2021 to March 31, 2022
Issuances of common stock, net of offering costs
Issuances of common stock upon cashless exercise of pre-funded warrants
from December 31, 2020 to December 31, 2021
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
from June 30, 2021 to September 30, 2021
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
1.Common stock offered 3,926,702 shares.
2.The number of shares of common stock to be outstanding immediately after the offering is based on 15,480,811 shares of common stock outstanding as of March 31, 2021.
From March 31, 2021 to June 30, 2021
Issuance of common stock under equity plans
from December 31, 2020 to March 31, 2021
Issuance of common stock under equity plans
From December 31, 2019 to December 31, 2020
Issuance of common stock under equity plans
Issuances of common stock and warrants, net of offering costs
Issuance of common stock in exchange for services
1.Common stock offered by the company 520,291 shares.
2.The number of shares of common stock to be outstanding immediately after the offering is based on 14,775,206 shares of common stock outstanding as of September 30, 2020, after giving effect to sale of 1,092,553 shares of common stock in a prior registered direct offering in December 2020.
1.Common stock offered by the company 1,092,553 shares.
2.The number of shares of common stock to be outstanding immediately after the offering is based on 13,682,653 shares of common stock outstanding as of September 30, 2020.
From June 30, 2020 to September 30, 2020
Issuances of common stock and warrants, net of offering costs
From March 31, 2020 to June 30, 2020
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
From December 31, 2019 to March 31, 2020
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
Issuance of common stock in exchange for services
from December 31, 2018 to December 31, 2019
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
On November 6, 2019, TRACON Pharmaceuticals, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”) at which the Company’s stockholders approved a proposal to amend the Company’s Amended and Restated Certificate of Incorporation to (i) effect a reverse stock split of the Company’s outstanding common stock at a ratio in the range of one-for-five to one-for-twenty, with such ratio to be determined in the discretion of the Company’s board of directors and with such reverse stock split to be effected at such time and date, if at all, as determined by the Company’s board of directors in its sole discretion, and (ii) reduce the number of authorized shares of the Company’s common stock in a corresponding proportion to the reverse stock split, rounded to the nearest whole share (collectively, the “Reverse Split Proposal”).
from March 31, 2019 to June 30,2019
Issuance of common stock under equity plans
From December 31, 2018 To March 31, 2019
Issuance of common stock under equity plans
From December 31, 2017 To December 31, 2018
Issuance of common stock under equity plans
Issuances of common stock and warrants, net of offering costs
From December 31, 2016 To December 31, 2017
Issuance of common stock under equity plans
Issuances of common stock, net of offering costs
From December 31, 2015 to December 31, 2016
Issuance of common stock under equity plans
Issuance of common stock in a public offering, net of offering costs
Other issuances of common stock, net
Issuance of common stock in exchange for services
from December 31, 2014 to December 31, 2015
Conversion of redeemable convertible preferred stock into common stock at initial public offering
Initial public offering and private placement of common stock for cash of $10 per share, net of offering costs
Issuance of common stock under equity plans
On January 16, 2015, the Company effected a one-for-3.87 reverse stock split of its common stock (the Reverse Stock Split).
the conversion of all our outstanding redeemable convertible preferred stock as of September 30, 2014 into an aggregate of 6,369,567 shares of common stock, which will occur automatically in connection with the closing of this offering; a 1-for-3.87 reverse stock split of our common stock effected in January 2015.
On January 16, 2015, the Company effected a one-for-3.87 reverse stock split of its common stock (the Reverse Stock Split).
from December 31, 2013 to December 31, 2014
Issuance of Series B redeemable convertible preferred stock in September for cash of $2.1935 per share, net of offering costs of $1,546
Exercise of common stock options
from December 31, 2013 to September 30, 2014
Issuance of Series B redeemable convertible preferred stock in September for cash of $2.1935 per share, net of offering costs of $1,530 (unaudited)
Exercise of common stock options (unaudited)